Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Acq. announced
Quarterly results
Director departure
Appointed director

WaferGen Bio-systems, Inc. (WGBS) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/23/2017 EFFECT Form EFFECT - Notice of Effectiveness
03/23/2017 EFFECT Form EFFECT - Notice of Effectiveness
03/23/2017 EFFECT Form EFFECT - Notice of Effectiveness
03/13/2017 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
03/13/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/13/2017 POS AM Form POS AM - Post-Effective amendments for registration statement
03/13/2017 POS AM Form POS AM - Post-Effective amendments for registration statement
03/13/2017 POS AM Form POS AM - Post-Effective amendments for registration statement
03/13/2017 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement
03/13/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/13/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/13/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/13/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/13/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/13/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/13/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/01/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
03/01/2017 8-K Quarterly results
02/23/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2017 EFFECT Form EFFECT - Notice of Effectiveness
02/15/2017 8-K Form 8-K - Current report
01/06/2017 SC 13G/A SABBY MANAGEMENT, LLC reports a 10% stake in WaferGen Bio-systems, Inc.
11/28/2016 8-K Form 8-K - Current report
11/28/2016 SC 13G WaferGen Bio-systems, Inc. reports a 5.3% stake in WaferGen Bio-systems Inc.
11/28/2016 SC 13G Opaleye Management Inc. reports a 5.1% stake in WaferGen Bio-systems Inc.
11/15/2016 8-K Form 8-K - Current report
11/10/2016 10-Q Quarterly Report for the period ended September 30, 2016
11/08/2016 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/08/2016 8-K Quarterly results
Docs: "WaferGen Bio-systems Reports Results for Third Quarter 2016 Year-to-Date Revenues Represent 44% Growth over First Nine Months of 2015 FREMONT, California – November 8, 2016 – WaferGen Bio-systems, Inc. , a life sciences company focused on developing and commercializing technology platforms for genomic solutions, announced today its financial results for the third quarter ended September 30, 2016. Key Recent Highlights"
10/31/2016 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/31/2016 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Investor Contact:"
10/28/2016 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/28/2016 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Letter to stockholders, sent by WaferGen Bio-systems, Inc., furnished herewith"
10/27/2016 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy